MGX Stock Analysis: Buy, Sell, or Hold?

MGX - Metagenomi, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.41
-0.01 (-0.70%) ▼
5d: +1.44%
30d: +1.44%
90d: -8.44%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 12, 2026 2d

Get Alerted When MGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: MGX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MGX is currently trading at $1.41, which is considered fair relative to its 30-day fair value range of $1.35 to $1.47.

Technical Outlook: Technically, MGX is in a strong downtrend. Immediate support is located at $1.33, while resistance sits at $1.52.

Market Sentiment: MGX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.33 (+561.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $1.35 - $1.47
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 50.0%

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 561.9% below Wall St target ($9.33)

Trading Range Analysis

30-Day Trading Range $1.35 - $1.47
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $1.33
Resistance Level $1.52
Current Trend Strong Downtrend
Technical data as of May 8, 2026

Fundamental Context

Forward P/E (Next Year Est.) -0.77
Wall Street Target $9.33 (+561.9%)
Revenue Growth (YoY) -59.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 08, 2026 9:49 PM ET
Data refreshes hourly during market hours. Next update: 10:49 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Pamela Wapnick SELL 1581 shares 2026-03-05
Brian C Thomas SELL 3830 shares 2025-12-05
Pamela Wapnick SELL 1576 shares 2025-12-05

Unlock Insider Activity

See real-time buying/selling by company executives for MGX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$548 60 BUY
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 54 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$53 60 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$875 52 HOLD
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$79 57 HOLD

More Analysis for MGX

MGX Technical Chart MGX Price Prediction MGX Earnings Date MGX Investment Advisor MGX Fair Price Analyzer MGX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals